{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T14:26:49Z","timestamp":1761056809063},"reference-count":33,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2002,1,1]],"date-time":"2002-01-01T00:00:00Z","timestamp":1009843200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Laboratory and Clinical Medicine"],"published-print":{"date-parts":[[2002,1]]},"DOI":"10.1067\/mlc.2002.120364","type":"journal-article","created":{"date-parts":[[2002,8,24]],"date-time":"2002-08-24T22:14:26Z","timestamp":1030227266000},"page":"50-58","source":"Crossref","is-referenced-by-count":22,"title":["The iron-loaded gerbil model revisited: Effects of deferoxamine and deferiprone treatment"],"prefix":"10.1067","volume":"139","author":[{"given":"C.","family":"Hershko","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Link","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.M.","family":"Konijn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Huerta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Rosenmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Reinus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1067\/mlc.2002.120364_bib1","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1159\/000203853","article-title":"Results of long-term iron chelating therapy","volume":"95","author":"Gabutti","year":"1996","journal-title":"Acta Haematol"},{"key":"10.1067\/mlc.2002.120364_bib2","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1056\/NEJM199409013310903","article-title":"Survival of medically treated patients with homozygous \u03b2 thalassemia","volume":"331","author":"Olivieri","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1067\/mlc.2002.120364_bib3","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1056\/NEJM199808133390701","article-title":"Long-term safety and effectiveness of iron-chelation therapy with deferiprone for thalassemia major","volume":"339","author":"Olivieri","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1067\/mlc.2002.120364_bib4","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1182\/blood.V91.1.295","article-title":"Long-term trial of deferiprone in 51 transfusion-dependent iron overloaded patients","volume":"91","author":"Hoffbrand","year":"1998","journal-title":"Blood"},{"key":"10.1067\/mlc.2002.120364_bib5","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1056\/NEJM199504063321404","article-title":"Iron-chelation therapy with oral deferiprone in patients with thalassemia major","volume":"332","author":"Olivieri","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1067\/mlc.2002.120364_bib6","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1111\/j.1365-2141.1995.tb05274.x","article-title":"Results of long-term deferiprone (L1) therapy: a report by the International Study Group on Oral Iron Chelators","volume":"91","author":"Al-Refaie","year":"1995","journal-title":"Br J Haematol"},{"key":"10.1067\/mlc.2002.120364_bib7","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1046\/j.1365-2141.2000.01866.x","article-title":"Safety profile of the oral iron chelator deferiprone: a multicentre study","volume":"108","author":"Cohen","year":"2000","journal-title":"Br J Haematol"},{"key":"10.1067\/mlc.2002.120364_bib8","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1046\/j.1365-2141.1998.00725.x","article-title":"Liver iron and fibrosis during long-term treatment with deferiprone in Swiss thalassaemic patients","volume":"101","author":"Tondury","year":"1998","journal-title":"Br J Haematol"},{"key":"10.1067\/mlc.2002.120364_bib9","first-page":"606A","article-title":"Absence of deferiprone-induced hepatic fibrosis: a multi-center study [abstract]","volume":"96","author":"Wanless","year":"2000","journal-title":"Blood"},{"key":"10.1067\/mlc.2002.120364_bib10","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1111\/j.1749-6632.1990.tb24320.x","article-title":"The development of hydroxypyridin-4-ones as orally active iron chelators","volume":"612","author":"Hider","year":"1990","journal-title":"Ann N Y Acad Sci"},{"key":"10.1067\/mlc.2002.120364_bib11","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/BF00144120","article-title":"Potentiation of iron accumulation in cardiac myocytes during the treatment of iron overload in gerbils with the hydroxypyridone iron chelator CP94","volume":"7","author":"Carthew","year":"1994","journal-title":"Biometals"},{"key":"10.1067\/mlc.2002.120364_bib12","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1111\/j.1365-2141.1993.tb08660.x","article-title":"Contrasting interspecies efficacy and toxicology of 1,2-diethyl-3-hydroxypyrid- 4-one, CP94, relates to differing metabolism of the iron chelating site","volume":"85","author":"Porter","year":"1993","journal-title":"Br J Haematol"},{"key":"10.1067\/mlc.2002.120364_bib13","first-page":"256","article-title":"Urinary metabolic profiles in human and rat of 1,2-dimethyl and 1,2-diethyl-substituted 3-hydroxypyrid-4-ones","volume":"20","author":"Singh","year":"1992","journal-title":"Drug Metab Dispos"},{"key":"10.1067\/mlc.2002.120364_bib14","first-page":"9","article-title":"A simple technique for measuring storage iron concentrations in formalinized liver samples","volume":"33","author":"Torrance","year":"1968","journal-title":"S Afr I Med Sci"},{"key":"10.1067\/mlc.2002.120364_bib15","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S0022-2143(99)90011-2","article-title":"Cardioprotective effect of alpha-tocopherol, ascorbate, deferoxamine, and deferiprone: mitochondrial function in cultured, iron-loaded heart cells","volume":"133","author":"Link","year":"1999","journal-title":"J Lab Clin Med"},{"key":"10.1067\/mlc.2002.120364_bib16","series-title":"Statistics at square one","article-title":"Exact probability test","author":"Swinscow","year":"2001"},{"key":"10.1067\/mlc.2002.120364_bib17","series-title":"Computer programs for epidemiologists: PEPI version 3.01","author":"Abramson","year":"1999"},{"key":"10.1067\/mlc.2002.120364_bib18","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","article-title":"Nonparametric estimation from incomplete observations","volume":"53","author":"Kaplan","year":"1958","journal-title":"J Am Stat Assoc"},{"key":"10.1067\/mlc.2002.120364_bib19","first-page":"217","article-title":"A unique rodent model for both the cardiotoxic and hepatotoxic effects of prolonged iron overload","volume":"69","author":"Carthew","year":"1993","journal-title":"Lab Invest"},{"key":"10.1067\/mlc.2002.120364_bib20","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1002\/hep.1840130322","article-title":"Rapid induction of hepatic fibrosis in the gerbil after the parenteral administration of iron-dextran complex","volume":"13","author":"Carthew","year":"1991","journal-title":"Hepatology"},{"key":"10.1067\/mlc.2002.120364_bib21","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1172\/JCI117861","article-title":"Molecular and cellular aspects of iron-induced hepatic cirrhosis in rodents","volume":"95","author":"Pietrangelo","year":"1995","journal-title":"J Clin Invest"},{"key":"10.1067\/mlc.2002.120364_bib22","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1002\/hep.510270622","article-title":"Hepatic stellate cells are not subjected to oxidant stress during iron-induced fibrogenesis in rodents","volume":"27","author":"Montosi","year":"1998","journal-title":"Hepatology"},{"key":"10.1067\/mlc.2002.120364_bib23","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1161\/01.CIR.100.6.675","article-title":"Decreased sodium and increased transient outward potassium currents in iron-loaded cardiac myocytes. Implications for the arrhythmogenesis of human siderotic heart disease","volume":"100","author":"Kuryshev","year":"1999","journal-title":"Circulation"},{"key":"10.1067\/mlc.2002.120364_bib24","doi-asserted-by":"crossref","first-page":"553","DOI":"10.2165\/00003495-199958030-00021","article-title":"Deferiprone. A review of its clinical potential in iron overload in \u03b2-thalassaemia major and other transfusion-dependent diseases","volume":"58","author":"Barman Balfour","year":"1999","journal-title":"Drugs"},{"key":"10.1067\/mlc.2002.120364_bib25","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1046\/j.1365-2141.1998.00726.x","article-title":"Iron chelators for thalassaemia","volume":"101","author":"Hershko","year":"1998","journal-title":"Br J Haematol"},{"key":"10.1067\/mlc.2002.120364_bib26","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1046\/j.1365-2141.2000.02406.x","article-title":"Annotation. Oral iron chelation therapy for thalassaemia: an uncertain scene","volume":"111","author":"Pippard","year":"2000","journal-title":"Br J Haematol"},{"key":"10.1067\/mlc.2002.120364_bib27","first-page":"399","article-title":"The histogenesis of hepatoma occurring spontaneously in a strain of sand rats (Psammomys obesus)","volume":"90","author":"Ungar","year":"1978","journal-title":"Am J Pathol"},{"key":"10.1067\/mlc.2002.120364_bib28","unstructured":"Hershko C, Link G, Konijn AM. Protective effect of iron chelators: comparative studies with deferoxamine and deferiprone. In: 7th International Conference on Thalassaemia and the Haemoglobinopathies; 1999; Bangkok, Thailand. p. 166-7."},{"key":"10.1067\/mlc.2002.120364_bib29","unstructured":"Schoeb TR. Diseases of gerbils. PAT 707, Pathology of laboratory animals II. Winter Quarter 1989-1990 Taxonomy. Department of Comparative Medicine, University of Alabama, Birmingham. Available at: http:\/\/netvet.wustl.edu\/species\/gerbils."},{"key":"10.1067\/mlc.2002.120364_bib30","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1182\/blood.V92.2.632","article-title":"The iron chelator L1 potentiates oxidative damage in iron-loaded liver cells","volume":"92","author":"Cragg","year":"1998","journal-title":"Blood"},{"key":"10.1067\/mlc.2002.120364_bib31","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1023\/A:1018312113969","article-title":"Liver iron depletion and toxicity of the iron chelator deferiprone (L1, CP20) in the guinea pig","volume":"10","author":"Wong","year":"1997","journal-title":"Biometals"},{"key":"10.1067\/mlc.2002.120364_bib32","unstructured":"Ramm GA, Britton RS, Brunt EM, O'Neill R, Bacon B. Hepatic iron overload in pathogen-free gerbils does not result in bridging fibrosis or cirrhosis. In: Bioiron 99, World Congress on Iron Metabolism; May 23-28, 1999; Sorrento, Naples, Italy. Abstract 327."},{"key":"10.1067\/mlc.2002.120364_bib33","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/S0021-9975(08)80042-4","article-title":"Hepatic fibrosis and iron accumulation due to endotoxin induced hemorrhage in the gerbil","volume":"104","author":"Carthew","year":"1991","journal-title":"J Comp Pathol"}],"container-title":["Journal of Laboratory and Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022214302116088?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022214302116088?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,12,16]],"date-time":"2019-12-16T01:31:45Z","timestamp":1576459905000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022214302116088"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,1]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2002,1]]}},"alternative-id":["S0022214302116088"],"URL":"https:\/\/doi.org\/10.1067\/mlc.2002.120364","relation":{},"ISSN":["0022-2143"],"issn-type":[{"value":"0022-2143","type":"print"}],"subject":[],"published":{"date-parts":[[2002,1]]}}}